Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Cellartis AB
Mandate

Vinge advises Cellartis AB

September 26, 2011

Vinge has advised the owners of Cellartis in connection with the sale of Cellartis AB to Cellectis S.A., a company listed on NYSE Euronext in Paris. The owners consist of InnovationsKapital among other venture capital investers as well as the company’s founders and employees. Cellartis has developed world-leading products based on pluripotent stem cells. Cellartis and Cellectis will jointly become a world-leading actor within R&D and development of products and services relating to regenerative and medical applications.

The purchase price consists of a cash element of € 16,400,000, and 1,930,000 in newly-issued Cellectis shares.

Vinge’s team primarily consisted of Anders Strid, Fredrik Sonander, Michael Sterner, Johanna Björnum Nyström, Emma Kero Ljungberg and Tove Bremell.

 
   

Related

Vinge advises Ambea on the acquisition of Validia

 Vinge has acted as advisor to Ambea AB (publ) together with the Finnish law firm Krogerus in connection with the acquisition of Validia Oy from Invalidiliitto, the Finnish Association for the Disabled, a leading care provider in Finland. Through the acquisition, Ambea establishes a presence in the Finnish market and strengthens its position as the only care provider with operations in the four largest Nordic countries. The purchase price amounts to a total of SEK 1, 382 million.
March 12, 2025

Vinge advises on the sale of Road Rental

 Vinge has advised Sobro and other shareholders in connection with the sale of Road Rental to BUKO Group, a leading European actor within temporary traffic management solutions. This strategic partner will give Road Rental access to a broad international network, strong resources and expertise which will enable continued expansion in Sweden as well as the rest of Scandinavia.
March 12, 2025

Vinge has advised Röko in connection with its listing on Nasdaq Stockholm

 Vinge has advised Röko AB (publ) (“Röko”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on March 4, 2025 and the first day of trading is March 11, 2025.
March 11, 2025